Hepalink Pharma IPO Initiation: Take a Chance on Me
Shenzhen Hepalink Pharma Co., Ltd. (002399 CH) is a leading China-based pharmaceutical company with global businesses in pharmaceutical, innovative...
725 Views
Long Pharmaron/Short Wuxi: Take Profit Now, A-Share Pullback the Key Risk
Pharmaron, the second-largest contract research organization (CRO) in China, was listed in Hong Kong on November 28th. The deal was anchored by a...
448 Views
Last Week in Event SPACE: Pharmaron, TOPIX Reorganisation, 2019 M&A Round-Up
Last Week in Event SPACE ... At a 33% A-H premium, there should be upside for Pharmaron Beijing Co Ltd-H (3759 HK)'s H shares when referenced...
417 Views
Pharmaron (康龙化成) Post-IPO: A/H Convergence Post Connect Inclusion Supports A Trade
Pharmaron, the second-largest contract research organization (CRO) in China, was listed in Hong Kong on November 28th. The deal was anchored by a...
503 Views
ECM Weekly (1 Dec 2019) - Venus Medtech, Alphamab, CMC REIT, XD, BAM
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It has...
460 Views